Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
2022 · The Lancet · 126 citations
https://doi.org/10.1016/s0140-6736(22)01659-2
C
Casey Liveringhouse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
498
Citations
12
h-index
13
i10-index
Casey Liveringhouse is an academic researcher from Moffitt Cancer Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Radiotherapy Techniques & Sarcoma Diagnosis and Treatment. The author has an h-index of 12, co-authored 43 publications.
Papers by this author
worksUtilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management
2019 · EBioMedicine · 59 citations
https://doi.org/10.1016/j.ebiom.2019.08.019
Intricacies of human–AI interaction in dynamic decision-making for precision oncology
2025 · Nature Communications · 27 citations
https://doi.org/10.1038/s41467-024-55259-x
Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator
2023 · Physics and Imaging in Radiation Oncology · 14 citations
https://doi.org/10.1016/j.phro.2023.100505
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions
2024 · Communications Medicine · 9 citations
https://doi.org/10.1038/s43856-024-00526-7
The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes
2020 · Journal of Geriatric Oncology · 5 citations
https://doi.org/10.1016/j.jgo.2020.08.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat